Hyderabad ki genomics company Mapmygenome ne Canada ki dnaPower Inc. ko acquire kar liya hai. Is deal se ab Indian firm direct North American market mein ghus rahi hai.
Hyderabad ki personal genomics company Mapmygenome ne ek bada kadam uthate hue Canada ki dnaPower Inc. ko acquire kar liya hai. Is move ka maqsad North America ke health diagnostics market mein apni jagah banana hai. Haan, deal kitne mein hui hai ye abhi tak reveal nahi kiya gaya hai, par is acquisition se Indian company ko Canada mein bana-banaya network mil gaya hai.
Business strategy kya hai?
Ab tak Mapmygenome India mein apne predictive genomic testing products ke liye famous rahi hai. dnaPower ke paas DNA testing, gut microbiome analysis, aur pharmacogenetics mein expertise hai. In dono ke milne se ek AI-powered platform taiyaar hoga, jo global level par longevity aur health insights offer karega.
Challenges kahan hain?
Dekhiye, North America ka market kaafi competitive hai. Wahan pehle se hi bade players baithe hain. Ab Mapmygenome ko apna 'multi-omics' approach prove karna hoga taaki wo locals se alag dikh sakein. Saath hi, cross-border integration bhi ek challenge hai—Canada ke strict data privacy laws aur healthcare regulations ko manage karna ab company ki leadership ki asli agni-pariksha hogi.
Market ab ye dekh raha hai ki yeh combined tech platform kitna fast scale hota hai aur kya yeh wahan ke users ka bharosa jeet paayegi.